Vietnam sees no fresh coronavirus cases for first time in more than two weeks
VOV.VN - The country reported no new cases of COVID-19 for the first time in more than two weeks, with the overall number of coronavirus infections standing at 841, the Ministry of Health said on August 10 morning.
One day earlier, Vietnam confirmed the 11th COVID-19 fatality being a 55-year-old Da Nang resident. She died of the COVID-19-related complication of acute respiratory distress syndrome (ARDS), multiorgan dysfunction syndrome, and gastrointestinal bleeding.
As many as 395 of the total active patients have given the all-clear, reaching a recovery rate of 47%. Among those treatment, nine have tested negative for the SARS-CoV-2 that causes the disease once, and 37 others at least twice.
Among the total in treatment, more than 182,260 are being put into isolation for health monitoring. According to the Ministry of Health, the biggest coronavirus epicentre is currently Da Nang General Hospital, the outbreak that has a fast spreading rate with 186 infections and secondary cases within the community.
Since July 23, the nation has confirmed 397 cases of COVID-19, of which 42 were imported ones, and 355 were locally-transmitted infections across 15 provinces and cities.
Meanwhile, at a meeting of the National Steering Committee for COVID-19 Prevention and Control held in Hanoi on August 9, Deputy Prime Minister Vu Duc Dam, head of the committee, ordered all citizens to raise their vigilance and take responsibility in the COVID-19 fight while suggesting every one should use the Bluezone app as a way of helping find and track the people of infection risks, thus delaying the virus spread to the wider community.
By August 10 morning, Vietnam has recorded a total of 841 COVID-19 cases, including 435 in treatment, and 384 cases found in the community following the resurface of the novel coronavirus in central Da Nang city on July 25.
There have been 11 fatalities to date, with all of them suffering from multiple comorbidities, including heart failure, cancer, diabetes and hypertension.